Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC+ — Claude Cuvelier (2025) | RDL Network
Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC+
Article 2025 en
Authors
CC
Claude Cuvelier
MB
Mehdi Brahmi
IS
Iradj Sobhani
Abstract
1 min read
For NF1-GISTs <30 mm, prognosis without relapse is excellent. RECKGIST score accurately predicts recurrence and needs to be validated in an external cohort, but it may help treatment decision making. No efficacy of adjuvant treatment was observed.
M Marinković, Nebojša Mujović, V Kovacevic, M Mihajlović, L Vajagić, Aleksandar Kocijančić, U Olafsson, Kasper Andersen, Davíð O. Arnar, Professor Gregory Lip, Tatjana Potpara
Discussion(0)
No comments yet. Be the first to comment.